Sygnature Discovery, a world-leading global CRO specializing in medicinal, synthetic, analytical, and high-throughput chemistry with over 900 scientists in Canada and the UK, replaced its legacy ELN with Revvity Signals Notebook to unify its operations. The highly flexible solution enabled tailored workflows across departments, improved data consistency via Samples for compliance and patents, and supported incremental rollout through a test environment. This bound global business units into a single research operation, streamlining collaboration, accelerating delivery of 21 candidate molecules to clinical trials, and enhancing efficiency in a competitive landscape.

Join for free to read